These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35961779)

  • 81. Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
    Ahmed-Belkacem A; Redjoul R; Brillet R; Ahnou N; Leclerc M; López-Molina DS; Soulier A; Gourgeon A; Rodriguez C; Maury S; Pawlotsky JM; Fourati S
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146735
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Host-related immunodeficiency in the development of multiple myeloma.
    Dosani T; Mailankody S; Korde N; Manasanch E; Bhutani M; Tageja N; Roschewski M; Kwok M; Kazandjian D; Costello R; Burton D; Zhang Y; Liewehr D; Steinberg SM; Maric I; Landgren O
    Leuk Lymphoma; 2018 May; 59(5):1127-1132. PubMed ID: 28792255
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity.
    Lucas C; Vogels CBF; Yildirim I; Rothman JE; Lu P; Monteiro V; Gehlhausen JR; Campbell M; Silva J; Tabachnikova A; Peña-Hernandez MA; Muenker MC; Breban MI; Fauver JR; Mohanty S; Huang J; ; Shaw AC; Ko AI; Omer SB; Grubaugh ND; Iwasaki A
    Nature; 2021 Dec; 600(7889):523-529. PubMed ID: 34634791
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance - Relationship With Selected Immune And Clinical Parameters.
    Pasiarski M; Sosnowska-Pasiarska B; Grywalska E; Stelmach-Gołdyś A; Kowalik A; Góźdź S; Roliński J
    Clin Interv Aging; 2019; 14():1741-1749. PubMed ID: 31631993
    [TBL] [Abstract][Full Text] [Related]  

  • 86. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.
    Epsi NJ; Richard SA; Lindholm DA; Mende K; Ganesan A; Huprikar N; Lalani T; Fries AC; Maves RC; Colombo RE; Larson DT; Smith A; Chi SW; Maldonado CJ; Ewers EC; Jones MU; Berjohn CM; Libraty DH; Edwards MS; English C; Rozman JS; Mody RM; Colombo CJ; Samuels EC; Nwachukwu P; Tso MS; Scher AI; Byrne C; Rusiecki J; Simons MP; Tribble D; Broder CC; Agan BK; Burgess TH; Laing ED; Pollett SD;
    Clin Infect Dis; 2023 Feb; 76(3):e439-e449. PubMed ID: 35608504
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine.
    Vanetti C; Stracuzzi M; Crivellaro E; Ciciliano F; Garziano M; Fenizia C; Biasin M; Rubinacci V; Amendola A; Tanzi E; Zuccotti GV; Clerici M; Giacomet V; Trabattoni D
    Front Immunol; 2023; 14():1301766. PubMed ID: 38250079
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination.
    Graninger M; Camp JV; Aberle SW; Traugott MT; Hoepler W; Puchhammer-Stöckl E; Weseslindtner L; Zoufaly A; Aberle JH; Stiasny K
    Front Immunol; 2022; 13():888794. PubMed ID: 35711424
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection.
    Kang CK; Shin HM; Choe PG; Park J; Hong J; Seo JS; Lee YH; Chang E; Kim NJ; Kim M; Kim YW; Kim HR; Lee CH; Seo JY; Park WB; Oh MD
    BMC Med; 2022 May; 20(1):181. PubMed ID: 35508998
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination.
    Zedan HT; Smatti MK; Thomas S; Nasrallah GK; Afifi NM; Hssain AA; Abu Raddad LJ; Coyle PV; Grivel JC; Almaslamani MA; Althani AA; Yassine HM
    JAMA Netw Open; 2023 Jun; 6(6):e2319222. PubMed ID: 37389876
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination.
    Hernández-Luis P; Aguilar R; Pelegrin-Pérez J; Ruiz-Olalla G; García-Basteiro AL; Tortajada M; Moncunill G; Dobaño C; Angulo A; Engel P
    Front Immunol; 2022; 13():816389. PubMed ID: 35464418
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273.
    Markewitz R; Pauli D; Dargvainiene J; Steinhagen K; Engel S; Herbst V; Zapf D; Krüger C; Sharifzadeh S; Schomburg B; Leypoldt F; Rupp J; Görg S; Junker R; Wandinger KP
    Clin Microbiol Infect; 2022 May; 28(5):701-709. PubMed ID: 34547457
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization.
    Wang J; Guo C; Cai L; Liao C; Yi H; Li Q; Hu H; Deng Q; Lu Y; Guo Z; Chen Z; Lu J
    Front Immunol; 2021; 12():772511. PubMed ID: 34868035
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma.
    Goyal G; Rajkumar SV; Lacy MQ; Gertz MA; Buadi FK; Dispenzieri A; Hwa YL; Fonder AL; Hobbs MA; Hayman SR; Zeldenrust SR; Lust JA; Russell SJ; Leung N; Kapoor P; Go RS; Gonsalves WI; Kourelis TV; Warsame R; Kyle RA; Kumar SK
    Leukemia; 2019 May; 33(5):1273-1277. PubMed ID: 30787429
    [TBL] [Abstract][Full Text] [Related]  

  • 96. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
    Mrak D; Tobudic S; Koblischke M; Graninger M; Radner H; Sieghart D; Hofer P; Perkmann T; Haslacher H; Thalhammer R; Winkler S; Blüml S; Stiasny K; Aberle JH; Smolen JS; Heinz LX; Aletaha D; Bonelli M
    Ann Rheum Dis; 2021 Oct; 80(10):1345-1350. PubMed ID: 34285048
    [TBL] [Abstract][Full Text] [Related]  

  • 97. COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity.
    Erra L; Uriarte I; Colado A; Paolini MV; Seminario G; Fernández JB; Tau L; Bernatowiez J; Moreira I; Vishnopolska S; Rumbo M; Cassarino C; Vijoditz G; López AL; Curciarello R; Rodríguez D; Rizzo G; Ferreyra M; Ferreyra Mufarregue LR; Badano MN; Pérez Millán MI; Quiroga MF; Baré P; Ibañez I; Pozner R; Borge M; Docena G; Bezrodnik L; Almejun MB
    J Clin Immunol; 2023 Feb; 43(2):271-285. PubMed ID: 36251205
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
    O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH
    Front Immunol; 2021; 12():800723. PubMed ID: 34992610
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine.
    Nantel S; Bourdin B; Adams K; Carbonneau J; Rabezanahary H; Hamelin MÈ; McCormack D; Savard P; Longtin Y; Cheng MP; De Serres G; Corbeil J; Gilca V; Baz M; Boivin G; Quach C; Decaluwe H
    Front Immunol; 2022; 13():930252. PubMed ID: 36311736
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients.
    Zhang R; Shin BH; Gadsden TM; Petrosyan A; Vo A; Ammerman N; Sethi S; Huang E; Peng A; Najjar R; Atienza J; Kim I; Jordan SC
    Transpl Infect Dis; 2022 Apr; 24(2):e13813. PubMed ID: 35202497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.